secwatch.observer — SEC 8-K summary
======================================

Issuer:     AleAnna, Inc. (ANNA)
CIK:        0001845123
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001193125-24-036776
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Swiftmerge Acquisition Corp. terminates merger with HDL Therapeutics by mutual agreement
--------------------------------------------------------------------------------

- Merger agreement dated August 11, 2023 terminated as of February 14, 2024.
- No termination fee or other payment due to either party under the Mutual Termination Agreement.
- All parties released each other from any and all claims arising under the merger agreement.
- Confidentiality obligations between Swiftmerge and HDL Therapeutics survive the termination.
- Swiftmerge must now pursue an alternative business combination or face potential liquidation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845123/000119312524036776/0001193125-24-036776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845123/000119312524036776/d628914d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-036776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer